UNSPSC 51271611: Fexicaine

This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5N2K83R1L2. European Medicines Agency schedules Fexicaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07617MIG. Fexicaine generally arises in the molecular formula C25H34N2O4.

UNSPSC 51271611 Fexicaine is a Commodity code covering local anesthetic pharmaceutical products. State and local governments procure fexicaine primarily through cooperative purchasing vehicles that consolidate demand across multiple jurisdictions and facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a primary issuing body for generic multi-source pharmaceuticals including this commodity, bundling fexicaine with other OTC and generic drug products into broad RFPs that supply state agencies, local government facilities, and participating jurisdictions across multiple states including Oregon. Vendors must meet FDA compliance, current Good Manufacturing Practice (cGMP) certification, and Drug Supply Chain Security Act (DSCSA) requirements, maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), and carry commercial general liability insurance of $5,000,000 per occurrence and professional liability of $2,000,000.

MMCAP issued a Request for Proposal (S1070000015802) on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026 and contract effectiveness of July 1, 2026. The procurement is structured for two-year terms with optional MMCAP extensions, and pricing evaluation weighted 75 percent on price competitiveness, 10 percent on fixed pricing for the contract term, and 5 percent each on administrative compliance, EDI capability, and agreement to a 3 percent administrative fee. Vendors should expect performance penalties ranging from $200 to $1,500 per violation for reporting delays, missed onboarding timelines, or improper class-of-trade denials. The source identifies Minnesota and Oregon as participating jurisdictions; no specific budget or award value is disclosed.